Clinical Trials in Poland / NCT05100056
Recruiting
Observational
A Study of Brentuximab Vedotin in Adults With Hodgkin's Lymphoma
NCT05100056 · tracked via the Priya Life Science Poland tracker
Condition(s) studied
Hodgkin Lymphoma
Investigational drug(s) / intervention(s)
No Intervention
No Intervention: This is a non-interventional study.
Study summary
The main aim is to check how effective BV is for treating adults with HL.
Study medication will be prescribed according to the clinic's standard practice.
Participants will visit the study clinic 5 times, once every 12 weeks. When study treatment has completed, a follow-up visit will be scheduled every 3 months during the first year and every 4-6 months during the next year.
Eligibility
Inclusion Criteria:
1\. Adult participant (aged greater than or equal to \[\>=18\] years) that underwent or are candidates for ASCT and were enrolled in BV HL NDP receiving treatment according to the Summary of Product Characteristics for Adcetris and NDP.
Exclusion Criteria:
1. Currently participates or plans to participate in any interventional clinical trial.
2. Any other reason that, in the Investigator's opinion, makes the participant unsuitable to participate in this study.
Primary outcome measure(s)
- Progression Free Survival (PFS) as Assessed by Investigator — From initiation of BV treatment post-ASCT until disease progression or relapse, or death (up to 36 months)
PFS will be assessed by investigator and defined as the time from the first dose of BV post ASCT until the first occurrence of disease progression or relapse, or death for any reason. Disease progression is at least a 50 percent (%) increase in the size of lesions, or the occurrence of new lesions. It will be analyzed using Kaplan-Meier method.
Trial sites (13)
| Facility | City | Region | Status |
|---|---|---|---|
| Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wroclawiu | Wroclaw | Dolnoslskie | Recruiting |
| Szpital Kliniczny Przemienienia Panskiego Uniwersytetu Medycznego im. Karola Marcinkowskiego w Poznaniu | Poznan | Greater Poland Voivodeship | Recruiting |
| Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy Oddzial w Krakowie | Krakow | Lesser Poland Voivodeship | Recruiting |
| Samodzielny Publiczny Zaklad Opieki Zdrowotnej Szpital Uniwersytecki w Krakowie | Krakow | Lesser Poland Voivodeship | Recruiting |
| Centrum Onkologii Ziemi Lubelskiej im. sw. Jana z Dukli | Lublin | Lublin Voivodeship | Recruiting |
| NU-MED Specjalistyczny Szpital Onkologiczny Tomaszow Mazowiecki | Tomaszow Mazowiecki | Masovian Voivodeship | Recruiting |
| Uniwersyteckie Centrum Kliniczne WUM | Warsaw | Masovian Voivodeship | Recruiting |
| Instytut Hematologii i Transfuzjologii | Warsaw | Masovian Voivodeship | Recruiting |
| Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy | Warsaw | Masovian Voivodeship | Recruiting |
| Uniwersyteckie Centrum Kliniczne, Gdansk | Gdansk | Pomeranian Voivodeship | Recruiting |
| Samodzielny Publiczny Szpital Kliniczny im. Andrzeja Mieleckiego Slskiego Uniwersytetu Medycznego w Katowicach | Katowice | Slskie | Recruiting |
| Samodzielny Publiczny Zaklad Opieki Zdrowotnej MSWiA z Warminsko - Mazurskim Centrum Onkologii w Olsztynie | Olsztyn | Warmian-Masurian Voivodeship | Recruiting |
| Wojewodzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii, im. M. Kopernika w Lodzi | Lodz | Łódź Voivodeship | Recruiting |
More Takeda trials in Poland
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05100056 on ClinicalTrials.gov ↗ ← All trials in Poland